Hao Wang
31Patents
3h-index
108Co-inventors
62Inventor score
Filing activity: Nov 22, 2006 → Jan 9, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9034893B2 | Process for reducing contaminating michael acceptor levels in oxycodone and other compositions | Physics | 7 | Active |
| US7875623B2 | Process for reducing contaminating Michael acceptor levels in oxycodone and other compositions | Physics | 6 | Active |
| US9447187B2 | Use of an anti-CD200 antibody for prolonging the survival of allografts | Physics | 3 | Active |
| US12031012B2 | Antidegradant composition, antidegradant master batch and rubber composition | Chemistry; Metallurgy | 1 | Active |
| US10749065B2 | Preparation method and application of light-responsive LED based on GaN/CsPbBrxI3-x heterojunction | Electricity | 1 | Active |
| US11795200B2 | Nano small peptide and its use in preparation of drugs for treating and preventing fundus vascular diseases | Chemistry; Metallurgy | 1 | Active |
| US9403838B2 | Process for reducing contaminating Michael acceptor levels in oxycodone and other compositions | Physics | 1 | Active |
| US11738010B2 | Oxazolidinones as TarO inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11918951B2 | MOF compositions for selective separation of hydrocarbons | Performing Operations; Transporting | 0 | Active |
| US11752128B2 | Benzimidazoles and indoles as taro inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11746023B2 | Basic copper chloride particulate matter and preparation method therefor | Emerging Cross-Sectional Technologies | 0 | Active |
| US12297296B2 | Nano small peptide and its use in preparation of drugs for treating and preventing fundus vascular diseases | Chemistry; Metallurgy | 0 | Active |
| US12031037B2 | Rubber protective wax, preparation method and application thereof | Chemistry; Metallurgy | 0 | Active |
| US11141403B2 | Benzimidazoles and indoles as taro inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11141410B2 | Oxazolidinones as taro inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9019602B2 | Scattering screen system, method of manufacture and application thereof | Physics | 0 | Active |
| US11414411B2 | Chemical process for manufacturing monobactam antibiotic and intermediates thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11260032B2 | Method for preparing biofilm-coated drug nanocrystal and application thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12338253B2 | Nitrogen-containing polycyclic fused ring compound, pharmaceutical composition thereof, preparation method therefor and use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US8232270B2 | Bivalent (−)-meptazinol compounds and/or their salts, and their preparation and futilization | Human Necessities | 0 | Active |
| US10201174B2 | Process for reducing contaminating Michael acceptor levels in oxycodone and other compositions | Physics | 0 | Active |
| US12109551B2 | Rare-earth-manganese/cerium-zirconium-based composite compound, method for preparing same and use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11220436B2 | Basic zinc chloride particulate matter and preparation method therefor | Chemistry; Metallurgy | 0 | Active |
| US11655240B1 | Crystal form of compound and fumaric acid, pharmaceutical composition and method for treating coronavirus-induced diseases | Chemistry; Metallurgy | 0 | Active |
| US12319687B2 | Indole alkaloid compound in noni enzyme and preparation method and application thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.